BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 33787603)

  • 1. Association of dipeptidyl peptidase IV polymorphism, serum lipid profile, and coronary artery stenosis in patients with coronary artery disease and type 2 diabetes.
    Wang Z; Liu Y; Wang W; Qu H; Han Y; Hou Y
    Medicine (Baltimore); 2021 Apr; 100(13):e25209. PubMed ID: 33787603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between DPP4 gene polymorphism and serum lipid levels in Chinese type 2 diabetes individuals.
    Xing X; Han Y; Zhou X; Zhang B; Li Y; Wang Z; Liao L; Su L
    Neuropeptides; 2016 Dec; 60():1-6. PubMed ID: 27585937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms in dipeptidyl peptidase IV gene are associated with the risk of myocardial infarction in patients with atherosclerosis.
    Aghili N; Devaney JM; Alderman LO; Zukowska Z; Epstein SE; Burnett MS
    Neuropeptides; 2012 Dec; 46(6):367-71. PubMed ID: 23122333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender differences in variables associated with dipeptidyl peptidase 4 genetic polymorphisms in coronary artery disease.
    Chiang SM; Ueng KC; Yang YS
    Adv Clin Exp Med; 2020 Oct; 29(10):1181-1186. PubMed ID: 33030314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of DPP4 Gene Polymorphisms with Type 2 Diabetes Mellitus in Malaysian Subjects.
    Ahmed RH; Huri HZ; Al-Hamodi Z; Salem SD; Al-Absi B; Muniandy S
    PLoS One; 2016; 11(4):e0154369. PubMed ID: 27111895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5' ins/del and 3' VNTR polymorphisms in the apolipoprotein B gene in relation to lipids and coronary artery disease.
    Rebhi L; Omezzine A; Kchok K; Belkahla R; Ben Hadjmbarek I; Rejeb J; Ben Rejeb N; Nabli N; Bibi A; Massoud T; Abdelaziz A; Boughzala E; Bouslama A
    Clin Chem Lab Med; 2008; 46(3):329-34. PubMed ID: 18254714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of dipeptidyl peptidase IV polymorphism with clinicopathological characters of oral cancer.
    Chen PJ; Lu HJ; Nassef Y; Lin CW; Chuang CY; Lee CY; Chiu YW; Yang SF; Yang WE
    J Oral Pathol Med; 2022 Sep; 51(8):730-737. PubMed ID: 35880802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. rs10865710 polymorphism in PPARG promoter is associated with the severity of type 2 diabetes mellitus and coronary artery disease in a Chinese population.
    Song Y; Raheel TM; Jia A; Dai G; Liu L; Long X; He C
    Postgrad Med J; 2022 Oct; 98(1164):778-787. PubMed ID: 37062988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPARgamma gene C161T substitution alters lipid profile in Chinese patients with coronary artery disease and type 2 diabetes mellitus.
    Wan J; Xiong S; Chao S; Xiao J; Ma Y; Wang J; Roy S
    Cardiovasc Diabetol; 2010 Mar; 9():13. PubMed ID: 20334678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E gene polymorphism: effects on plasma lipids and risk of type 2 diabetes and coronary artery disease.
    Chaudhary R; Likidlilid A; Peerapatdit T; Tresukosol D; Srisuma S; Ratanamaneechat S; Sriratanasathavorn C
    Cardiovasc Diabetol; 2012 Apr; 11():36. PubMed ID: 22520940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein A-I, apolipoprotein B, high-sensitivity C-reactive protein and severity of coronary artery disease in Tunisian population.
    Hrira MY; Kerkeni M; Hamda BK; Chahed H; Ferchichi S; Addad F; Limam HB; Miled A
    Cardiovasc Pathol; 2012; 21(6):455-60. PubMed ID: 22425626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma nesfatin-1 and DDP-4 levels in patients with coronary artery disease: Kozani study.
    Kadoglou NPE; Korakas E; Lampropoulos S; Maratou E; Kassimis G; Patsourakos N; Plotas P; Moutsatsou P; Lambadiari V
    Cardiovasc Diabetol; 2021 Aug; 20(1):166. PubMed ID: 34389003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraoxonase Arg 192 allele is an independent risk factor for three-vessel stenosis of coronary artery disease.
    Vaisi-Raygani A; Ghaneialvar H; Rahimi Z; Tavilani H; Pourmotabbed T; Shakiba E; Vaisi-Raygani A; Kiani A; Aminian M; Alibakhshi R; Bartels C
    Mol Biol Rep; 2011 Nov; 38(8):5421-8. PubMed ID: 21465165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. rs629301 CELSR2 polymorphism confers a ten-year equivalent risk of critical stenosis assessed by coronary angiography.
    Noto D; Cefalù AB; Martinelli N; Giammanco A; Spina R; Barbagallo CM; Caruso M; Novo S; Sarullo F; Pernice V; Brucato F; Ingrassia V; Fayer F; Altieri GI; Scrimali C; Misiano G; Olivieri O; Girelli D; Averna MR
    Nutr Metab Cardiovasc Dis; 2021 May; 31(5):1542-1547. PubMed ID: 33810964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variants of dipeptidyl peptidase IV are linked to the clinicopathologic development of prostate cancer.
    Wen YC; Lin CY; Hsiao CH; Wang SS; Huang HC; Lin YW; Ho KH; Chang LC; Yang SF; Chien MH
    J Cell Mol Med; 2023 Sep; 27(17):2507-2516. PubMed ID: 37533175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The C allele of the reactive oxygen species modulator 1 (ROMO1) polymorphism rs6060566 is a biomarker predicting coronary artery stenosis in Slovenian subjects with type 2 diabetes mellitus.
    Tibaut M; Mankoč Ramuš S; Petrovič D
    BMC Med Genomics; 2020 Dec; 13(1):184. PubMed ID: 33302957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinase-3 gene polymorphism (rs3025058) affects markers atherosclerosis in type 2 diabetes mellitus.
    Pleskovič A; Letonja MŠ; Vujkovac AC; Starčević JN; Caprnda M; Curilla E; Mozos I; Kruzliak P; Prosecky R; Petrovič D
    Vasa; 2017 Aug; 46(5):363-369. PubMed ID: 28521653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation at the DPP4 locus influences apolipoprotein B levels in South Asians and exhibits heterogeneity in Europeans related to BMI.
    Bailey SD; Xie C; Paré G; Montpetit A; Mohan V; Yusuf S; Gerstein H; Engert JC; Anand SS;
    Diabetologia; 2014 Apr; 57(4):738-45. PubMed ID: 24362726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Butyrylcholinesterase K variant and the APOE-epsilon 4 allele work in synergy to increase the risk of coronary artery disease especially in diabetic patients.
    Vaisi-Raygani A; Rahimi Z; Tavilani H; Pourmotabbed T
    Mol Biol Rep; 2010 Apr; 37(4):2083-91. PubMed ID: 19685167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(ADP-Ribose) Polymerase Activity and Coronary Artery Disease in Type 2 Diabetes Mellitus: An Observational and Bidirectional Mendelian Randomization Study.
    Cui NH; Yang JM; Liu X; Wang XB
    Arterioscler Thromb Vasc Biol; 2020 Oct; 40(10):2516-2526. PubMed ID: 32757651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.